11-Hydroxy-THC

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Image:11-OH-THC.svg
11-Hydroxy-THC
Systematic (IUPAC) name
6a,7,8,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl- 6H-Dibenzo[b,d]pyran-9-methanol
Identifiers
CAS number 36557-05-8
ATC code  ?
PubChem 644022
Chemical data
Formula C21H30O3 
Mol. mass 330.461 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

11-Hydroxy-Δ9-tetrahydrocannabinol (11-OH-THC) is the main active metabolite of THC which is formed in the body after cannabis is smoked[1]. 11-hydroxy-THC has been shown to be active in its own right[2], but the effects produced are not necessarily identical to those of THC[3]; it is plausible that the biphasic action of cannabis might be explained by the action of the active metabolite of THC rather than by other compounds present in the plant such as cannabidiol, so that 11-hydroxy-THC might be responsible for causing certain effects such as sleepiness and increased appetite which are characteristically delayed and occur as the initial "high" is wearing off.

11-hydroxy-THC is subsequently metabolised further to 11-carboxy-THC, which is not psychoactive but may still play a role in the analgesic and anti-inflammatory effects of cannabis.

References

  1. ^ Johnson, J.R.; T.A. Jennison, M.A. Peat, R.L. Foltz (September-October 1984). "Stability of delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in blood and plasma.". Journal of Analytical Toxicology 8 (5): 202-204.
  2. ^ Turkanis, S.A.; R. Karler (July 1988). "Changes in neurotransmitter release at a neuromuscular junction of the lobster caused by cannabinoids". Neuropharmacology 27 (7): 737-742.
  3. ^ Hollister, L.E.; H.K. Gillespie (December 1975). "Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis". Clinical Pharmacology and Therapeutics 18 (6): 714-719.


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools